Sonidegib M48-[d4]
Sonidegib M48-[d4] is a labelled metabolite of Sonidegib. Sonidegib is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. It was approved by the FDA for treating basal-cell carcinoma in July 2015.
Supplier | BOC Sciences |
---|---|
Product # | BLP-004260 |
Pricing | Inquire |
Molecular Weight | 300.27 |
Molecular Formula | C15H7D4F3O3 |